National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 648424

History of Changes from the VAERS Wayback Machine

First Appeared on 2/14/2017

648424
VAERS Form:
Age:15.0
Gender:Female
Location:Foreign
Vaccinated:2009-04-15
Onset:2009-05-01
Submitted:2016-08-18
Entered:2016-08-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Diarrhoea, Dizziness, Dyskinesia, Dyspnoea, Dysuria, Headache, Infection, Muscular weakness, Nausea, Palpitations, Exercise tolerance decreased, Cognitive disorder, Tilt table test normal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Human papilloma virus Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Examinations or lab samples: The tilt table test shows that the patient does not fulfill the criteria for Postural Orthostatic Tachycardia Syndrome.
CDC 'Split Type': WAES1608DNK009252

Write-up:Information has been received from Sanofi Pasteur MSD (SPM) (MFR control number DK-1577272925-2016008229) on 17-AUG-2016. Case received from a physician via health authority on 15-AUG-2016 under reference number DK-DKMA-WBS-0004235. A 15-year-old female adolescent patient received GARDASIL, batch number Not available, Dose 1 via intramuscular route on 08-OCT-2008, GARDASIL, batch number Not available, Dose 2 via intramuscular route on 10-DEC-2008, GARDASIL, batch number Not available, Dose 3 via intramuscular route on 15-APR-2009. The patient experienced recurrent infection, headache, dizziness, palpitation, nausea, abdominal pain, diarrhea, voiding difficulty, shortness of breath, cognitive disorder involuntary muscle movement, weakness of legs/weakness of arms and exercise tolerance decreased on an unknown date. The patient stated that she experienced the first symptom recurrent infection 1 month after her 3rd vaccination. The other symptoms followed. Before her vaccinations, the patient did tennis, fitness, horse-back riding in total 9 hours a week. The tilt table test showed that the patient did not fulfill the criteria Postural Orthostatic Tachycardia Syndrome. Other vaccinations or medications unknown. The patient''s outcome was reported as not recovered/not resolved for headache, dizziness, palpitation, nausea, abdominal pain, diarrhea, voiding difficulty, shortness of breath, cognitive disorder, involuntary muscle movement, and weakness of legs/weakness of arms. The patient''s outcome was reported as unknown for recurrent infection and exercise tolerance decreased.


Changed on 9/14/2017

648424 Before After
VAERS Form:(blank) 1
Age:15.0
Gender:Female
Location:Foreign
Vaccinated:2009-04-15
Onset:2009-05-01
Submitted:2016-08-18
Entered:2016-08-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 3 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Abdominal pain, Diarrhoea, Dizziness, Dyskinesia, Dyspnoea, Dysuria, Headache, Infection, Muscular weakness, Nausea, Palpitations, Exercise tolerance decreased, Cognitive disorder, Tilt table test normal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Human papilloma virus Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Examinations or lab samples: The tilt table test shows that the patient does not fulfill the criteria for Postural Orthostatic Tachycardia Syndrome.
CDC 'Split Type': WAES1608DNK009252

Write-up:Information has been received from Sanofi Pasteur MSD (SPM) (MFR control number DK-1577272925-2016008229) on 17-AUG-2016. Case received from a physician via health authority on 15-AUG-2016 under reference number DK-DKMA-WBS-0004235. A 15-year-old female adolescent patient received GARDASIL, batch number Not available, Dose 1 via intramuscular route on 08-OCT-2008, GARDASIL, batch number Not available, Dose 2 via intramuscular route on 10-DEC-2008, GARDASIL, batch number Not available, Dose 3 via intramuscular route on 15-APR-2009. The patient experienced recurrent infection, headache, dizziness, palpitation, nausea, abdominal pain, diarrhea, voiding difficulty, shortness of breath, cognitive disorder involuntary muscle movement, weakness of legs/weakness of arms and exercise tolerance decreased on an unknown date. The patient stated that she experienced the first symptom recurrent infection 1 month after her 3rd vaccination. The other symptoms followed. Before her vaccinations, the patient did tennis, fitness, horse-back riding in total 9 hours a week. The tilt table test showed that the patient did not fulfill the criteria Postural Orthostatic Tachycardia Syndrome. Other vaccinations or medications unknown. The patient''s outcome was reported as not recovered/not resolved for headache, dizziness, palpitation, nausea, abdominal pain, diarrhea, voiding difficulty, shortness of breath, cognitive disorder, involuntary muscle movement, and weakness of legs/weakness of arms. The patient''s outcome was reported as unknown for recurrent infection and exercise tolerance decreased.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=648424&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166